Bill > S4760

This bill, the Pioneering Antimicrobial Subscriptions To End Up surging Resistance (PASTEUR) Act of 2020, aims to establish a program to develop antimicrobial innovations targeting the most challenging pathogens and most threatening infections. The key provisions include: 1) establishing a Committee on Critical Need Antimicrobials to develop a list of prioritized infections and regulations for favored characteristics of critical need antimicrobial drugs; 2) allowing the Secretary to provide transitional subscription contracts to antimicrobial developers prior to the full subscription contract program; 3) establishing a process for antimicrobial drugs to be designated as "critical need" and eligible for subscription contracts; 4) creating a subscription contract program to incentivize the development of critical need antimicrobial drugs, with contract amounts based on the drugs' favored characteristics; and 5) appropriating $11 billion to carry out the Act.